申请人:BioCryst Pharmaceuticals, Inc.
公开号:US20170128454A1
公开(公告)日:2017-05-11
Provided are compounds of Formula I:
as described herein. Compounds of Formula I are useful in methods of inhibiting viral RNA polymerase activity and viral replication. Also provided are pharmaceutical compositions comprising compounds of Formula I, as well as methods of treating viral infections using compounds of Formula I.